HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mohamadreza Amin Selected Research

galbanic acid

7/2021The effect of RGD-targeted and non-targeted liposomal Galbanic acid on the therapeutic efficacy of pegylated liposomal doxorubicin: From liposomal preparation to in-vivo studies.
2/2020Author Correction: Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma.
1/2019Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mohamadreza Amin Research Topics

Disease

11Neoplasms (Cancer)
06/2022 - 12/2013
4Carcinoma (Carcinomatosis)
02/2020 - 12/2013
3Hyperthermia
10/2021 - 12/2015
1Neuralgia (Stump Neuralgia)
10/2022
1Hyperalgesia
10/2022
1Necrosis
10/2022
1Pain (Aches)
10/2022
1Colonic Neoplasms (Colon Cancer)
07/2021
1Alzheimer Disease (Alzheimer's Disease)
12/2019
1Cognitive Dysfunction
12/2019
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
12/2019
1Melanoma (Melanoma, Malignant)
12/2015
1Hemorrhage
11/2009
1Dehydration (Water Stress)
11/2009

Drug/Important Bio-Agent (IBA)

8Pharmaceutical PreparationsIBA
10/2022 - 01/2015
8Liposomes (Liposome)IBA
02/2022 - 11/2009
4Peptides (Polypeptides)IBA
02/2022 - 12/2013
4liposomal doxorubicin (Doxil)FDA Link
07/2021 - 12/2013
3galbanic acidIBA
07/2021 - 01/2019
3arginyl-glycyl-aspartic acidIBA
07/2021 - 12/2013
2LigandsIBA
02/2022 - 12/2013
2coumarinIBA
07/2021 - 01/2019
2SesquiterpenesIBA
07/2021 - 01/2019
2Therapeutic UsesIBA
12/2019 - 01/2018
21-dodecylpyridoxal (PLD)IBA
01/2019 - 12/2013
2cyclic arginine-glycine-aspartic acid peptideIBA
12/2015 - 12/2013
2IntegrinsIBA
12/2015 - 12/2013
2Doxorubicin (Adriamycin)FDA LinkGeneric
12/2015 - 12/2013
1AcetylglucosamineIBA
10/2022
1Glucosamine (Dona)IBA
10/2022
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
10/2022
1Cell-Penetrating PeptidesIBA
02/2022
1Trans-Activators (Trans-Acting Factor)IBA
02/2022
1aspartic acid glycine arginineIBA
02/2022
1cyclo(arginylglycyl)IBA
07/2021
1Coloring Agents (Dyes)IBA
01/2021
1Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric
12/2019
1Protein CoronaIBA
01/2018
1Cytotoxins (Cytolysins)IBA
12/2015
1PolyethyleneimineIBA
01/2015
1Epirubicin (Ellence)FDA LinkGeneric
01/2015
1Silicon Dioxide (Silica)FDA LinkGeneric
01/2015
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2015
1SolutionsIBA
11/2009
1Immunoglobulin G (IgG)IBA
11/2009

Therapy/Procedure

4Therapeutics
06/2022 - 01/2015
1Ligation
10/2022
1Fluid Therapy (Oral Rehydration Therapy)
11/2009